Medicare Enrolled
Dr. George Keith, M.D.
Pulmonary Disease · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Keith from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Keith?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Keith
Dr. George Keith is a pulmonary disease specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Keith performed 2,705 Medicare services across 1,755 unique beneficiaries.
Between the years covered by Open Payments, Dr. Keith received a total of $21,816 from 63 pharmaceutical and/or device companies across 1154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Keith is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in TX
$21,816 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,705
Medicare services
Top 11% in TX for pulmonary disease
1,755
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~135 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
606 | $64 | $140 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
568 | $68 | $125 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
326 | $95 | $175 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
211 | $131 | $300 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
146 | $103 | $240 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
116 | $76 | $85 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
116 | $31 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
94 | $129 | $275 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
82 | $93 | $225 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
64 | $32 | $90 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
61 | $11 | $40 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
61 | $160 | $250 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
55 | $22 | $120 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
36 | $85 | $240 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $42 | $100 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
27 | $40 | $120 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
24 | $25 | $95 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
23 | $8 | $95 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $132 | $325 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
14 | $46 | $75 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
14 | $61 | $95 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
12 | $44 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$21,816
Total received (2018-2024)
Avg $3,117/year across 7 years
Top 11% in TX for pulmonary disease
63
Companies
1,154
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,730 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$86 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,511
2023
$3,543
2022
$3,413
2021
$2,878
2020
$2,390
2019
$2,991
2018
$3,090
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$3,191
AstraZeneca Pharmaceuticals LP
$3,085
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,257
Actelion Pharmaceuticals US, Inc.
$1,573
Grifols USA, LLC
$1,106
Electromed, Inc.
$926
Mallinckrodt Hospital Products Inc.
$695
Philips Electronics North America Corporation
$678
Regeneron Healthcare Solutions, Inc.
$657
GENZYME CORPORATION
$643
Genentech USA, Inc.
$628
Mylan Specialty L.P.
$598
United Therapeutics Corporation
$496
Insmed, Inc.
$445
JAZZ PHARMACEUTICALS INC.
$380
Mallinckrodt LLC
$319
Harmony Biosciences LLC
$314
Bayer HealthCare Pharmaceuticals Inc.
$314
Gilead Sciences, Inc.
$242
Janssen Pharmaceuticals, Inc
$225
Axsome Therapeutics, Inc.
$195
Takeda Pharmaceuticals U.S.A., Inc.
$187
Amgen Inc.
$184
Sunovion Pharmaceuticals Inc.
$182
Intuitive Surgical, Inc.
$171
Philips North America LLC
$161
HARMONY BIOSCIENCES LLC
$146
Shire North American Group Inc
$143
Teva Pharmaceuticals USA, Inc.
$129
Merck Sharp & Dohme LLC
$125
Circassia Pharmaceuticals Inc
$123
ANI Pharmaceuticals, Inc.
$111
Novartis Pharmaceuticals Corporation
$92
Bayer Healthcare Pharmaceuticals Inc.
$91
Tactile Systems Technology Inc
$78
Inspire Medical Systems, Inc.
$77
CSL Behring
$73
Inogen, Inc.
$66
PFIZER INC.
$59
Mallinckrodt Enterprises LLC
$59
Avadel CNS Pharmaceuticals, LLC
$56
Paratek Pharmaceuticals, Inc.
$43
Phadia US Inc.
$41
Novo Nordisk Inc
$38
Exact Sciences Corporation
$29
3B Medical, Inc.
$28
Advanced Respiratory, Inc
$27
ARBOR PHARMACEUTICALS, INC.
$27
OptiNose US, Inc.
$26
SANOFI US SERVICES INC.
$25
SANOFI-AVENTIS U.S. LLC
$25
Exeltis, USA Inc.
$23
Biogen, Inc.
$22
Vapotherm Inc
$22
Pulmonx Corporation
$22
Vanda Pharmaceuticals Inc.
$22
Allergan Inc.
$20
Lilly USA, LLC
$20
Jazz Pharmaceuticals Inc.
$20
Resmed Corp
$17
IDORSIA PHARMACEUTICALS US INC
$15
Shionogi Inc
$13
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 39.1% of total payments
Associated products mentioned in payments ›
(7999) SRC Und · (8685) OEM Other · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · Astral · BELSOMRA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CHARTIS CATHETER · Cologuard Collection Kit · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Da Vinci Surgical System · Dymista · ELIQUIS · Edarbyclor · Esbriet · FARXIGA · FASENRA · Fetroja · Flexitouch Plus · GLASSIA · HETLIOZ · Horizant · INOGEN ONE G3 OXYGEN CONCENTRATOR · INSPIRE · ImmunoCAP · InogenOne · LONHALA MAGNAIR · LUMRYZ · LUNA · MOUNJARO · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · REMODULIN · Respiratoriy Care Undiv · SEEBRI · SKYCLARYS · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · WAKIX · WINREVAIR · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $806 per 100 Medicare services performed
Geographic Context
Pulmonary diseases within 10 mi
126
Per 100K population
2.6
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Keith is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), with low-engagement industry engagement in the top 11% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Keith experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Keith performed 606 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Keith receive payments from pharmaceutical companies?
Yes. Dr. Keith received a total of $21,816 from 63 companies across 1,154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Keith's costs compare to other pulmonary diseases in Houston?
Dr. Keith's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Keith) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Houston
Browse pulmonary diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology